Stewart Fabb

Stewart Fabb is a Research Fellow at Monash University, affiliated with the Drug Delivery, Disposition & Dynamics research group. His work spans pharmacology, virology, and translational medicine, contributing to global health challenges including cancer therapy and infectious disease prevention.

• Institution: Monash University
• Department: Drug Delivery Disposition & Dynamics
• Academic Rank: Research Fellow

Dr. Fabb’s research focuses on drug delivery systems, molecular pharmacology, and vaccine development. His expertise includes the pharmacokinetics of therapeutic agents, G protein-coupled receptor signaling, and the development of mRNA and recombinant protein vaccines for SARS-CoV-2. He also investigates the role of beta-blockers in controlling cancer metastasis, particularly in triple-negative breast cancer.

His recent publications highlight a strong trend in translational biomedical research, particularly in oncology and virology. Key themes include immune modulation in cancer, overcoming immune imprinting with novel vaccine designs, and understanding viral protein trafficking for improved gene therapy vectors.

While no specific awards are listed, his contributions to high-impact journals such as Science Translational Medicine and EBioMedicine reflect significant scientific recognition.

• Co-investigator in clinical trials for SARS-CoV-2 vaccines
• Active collaborator in multidisciplinary research teams focusing on cancer and infectious diseases

Dr. Fabb contributes to research networks involving immunology, pharmacology, and molecular biology, working with leading scientists in virology and oncology. His work supports the UN Sustainable Development Goals related to good health and well-being.